Invacare Holdings Corp (Invacare), previously Invacare Corp, designs, manufactures, and distributes medical devices for non-acute care, such as the home healthcare and long-term care markets. The company provides complex rehabilitation and post-acute care clinical solutions for congenital (muscular dystrophy, cerebral palsy, and spina bifida), acquired (spinal cord injury, stroke, post-acute recovery, traumatic brain injury, pressure ulcers) and degenerative (multiple sclerosis, ALS, age related, bariatric, chronic obstructive pulmonary disease (COPD)) ailments.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company aims to develop durable medical equipment to providers across global markets. It invests in applied research activities to ensure that new and enhanced design concepts are available to its businesses. - Major technologies include G-Trac tracking technology, and Ergo Move technology. In FY2022, it spent US$3.5 million on R&D activities which is 0.5% revenue declined 59.3% YoY due to cost-saving initiatives and dynamic controls.